¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Á¦11ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-³ì³»Àå : 2024-02-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Á¦11ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-³ì³»Àå : 2024-02-04
±³À°ÀÏÀÚ : 2024-02-04
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü ´ë°­´ç

±³À°ÁÖÁ¦ : 2024 Á¦11ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-³ì³»Àå

ÁÖÃÖ±â°ü : ¼­¿ï¾Æ»êº´¿ø
´ã´çÀÚ : Á¤ÇýÀ±
¿¬¶ôó : 02-3010-3680  

À̸ÞÀÏ : hyeyun0527@amc.seoul.kr

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í Àü¹®ÀÇ - »çÀü 60,000¿ø / ÇöÀå 80,000¿ø   Àü°øÀÇ - »çÀü 30,000¿ø / ÇöÀå 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 08:45~09:00 Event-based guidelines from recent landmark trials and studies ±è°íÀº(¿ï»êÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 09:00~09:15 Emerging glaucoma medication ÀÌÅÂÀº(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 09:15~09:30 MIGS - which device to choose for which patient ¹èÇü¿ø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 09:30~09:45 Micropulse laser therapy vs slow coagulation CPC: which is better? ÃÖÀç¿Ï(¼¾Æ®·²¼­¿ï¾È°ú)

Åä·Ð 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 09:45~09:55 Discussion ()

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 09:55~10:10 Evolving concepts on aqueous outflow ÇÑÁ¾Ã¶(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 10:10~10:25 Disc hemorrhage: clinical significance in glaucoma ÀÌÀºÁö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 10:25~10:40 Myopic disc change vs myopic glaucomatous damage ¹ÚÇý¿µ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 10:40~10:55 Neuroprotection therapy: where are we? ³ë½Â¼ö(Â÷ÀÇ°úÇдë)

Åä·Ð 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 10:55~11:05 Discussion ()

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 11:20~11:40 Challenging conventions in angle closure Benjamin Xu(University of Southern California, USA)

Åä·Ð 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 11:40~11:50 Discussion ()

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 11:50~12:10 Why is myopia a confounding factor for glaucoma diagnosis? Hitomi Saito(University of Tokyo, Japan)

Åä·Ð 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 12:10~12:20 Discussion ()

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 13:30~13:40 Gonioscopy vs AS-OCT - prefer gonioscopy ±è´ë¿ì(°æºÏÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 13:40~13:50 Gonioscopy vs AS-OCT - prefer AS-OCT ¹ÚÁöÇý(°í·ÁÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 13:50~14:00 Early LPI vs cataract extraction - prefer LPI Á¶À±Çý(°Ç±¹ÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 14:00~14:10 Early LPI vs cataract extraction - prefer cataract extraction Á¤°æÀÎ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 14:10~14:20 MIGS in angle closure glaucoma - prefer MIGS ÀÌ°æ¹Î(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 14:20~14:30 MIGS in angle closure glaucoma - no MIGS ÀÌÁö¿õ(ºÎ»êÀÇ´ë)

Åä·Ð 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 14:30~14:45 Discussion ()

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 15:00~15:15 Intraocular pressure management after PKP Á¤Á¾Áø(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 15:15~15:30 Thyroid-associated ophthalmopathy induced intractable glaucoma ÃÖÁø¾Æ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 15:30~15:45 Management of recurrent CMV-positive uveitic glaucoma ¼º¹Ì¼±(Àü³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 15:45~16:00 Complications after Ahmed valve implantation ¼Û¹Î°æ(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 02¿ù 04ÀÏ µ¿°ü ´ë°­´ç 16:00~16:15 Panel discussion ¹Ú»ó¿ì, À¯Á¤±Ç(Àü³²ÀÇ´ë, °í·ÁÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Á¦11ȸ ¾Æ»ê¾È°ú ½ÉÆ÷Áö¾ö-³ì³»Àå : 2024-02-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ (¿Â¶óÀÎ)2024³â ÆÀÇÇÁö¼Ç ¿¬¼ö°­Á : 2024-02-04
´ÙÀ½±Û ´ëÇѽɺÎÀüÇÐȸ µðÁöÅÐÇコ ½ÉÆ÷Áö¾ö : 2024-02-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 45 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 35 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 36 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 44 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 38 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 28 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 9 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 12 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 26 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 13 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 12 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 31 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 20 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 25 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 22 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷